Synmosa Biopharma (Taiwan) Price on October 17, 2024
| 4114 Stock | TWD 34.40 0.40 1.15% |
If you're considering investing in Synmosa Stock, it is important to understand the factors that can impact its price. As of today, the current price of Synmosa Biopharma stands at 34.40, as last reported on the 28th of November, with the highest price reaching 34.90 and the lowest price hitting 34.40 during the day. Synmosa Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.22, which indicates the firm had a -0.22% return per unit of risk over the last 3 months. Synmosa Biopharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Synmosa Biopharma's Variance of 0.5562, risk adjusted performance of (0.15), and Coefficient Of Variation of (518.16) to confirm the risk estimate we provide.
Synmosa Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Synmosa |
Sharpe Ratio = -0.2205
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 4114 |
Estimated Market Risk
| 0.75 actual daily | 6 94% of assets are more volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.22 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Synmosa Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Synmosa Biopharma by adding Synmosa Biopharma to a well-diversified portfolio.
Synmosa Biopharma Valuation on October 17, 2024
It is possible to determine the worth of Synmosa Biopharma on a given historical date. On October 17, 2024 Synmosa was worth 36.85 at the beginning of the trading date compared to the closed value of 36.85. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Synmosa Biopharma stock. Still, in general, we apply an absolute valuation method to find Synmosa Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Synmosa Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Synmosa Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 36.80 | 36.95 | 36.80 | 36.80 | 470,000 | |
10/17/2024 | 36.85 | 37.00 | 36.80 | 36.85 | 751,000 |
| 36.95 | 36.95 | 36.65 | 36.75 | 775,193 |
| Backtest Synmosa Biopharma | | | Synmosa Biopharma History | | | Synmosa Biopharma Valuation | Previous | Next |
Synmosa Biopharma Trading Date Momentum on October 17, 2024
| On October 18 2024 Synmosa Biopharma was traded for 36.75 at the closing time. The highest price during the trading period was 36.95 and the lowest recorded bid was listed for 36.65 . The volume for the day was 775.2 K. This history from October 18, 2024 contributed to the next trading day price decline. The daily price change to the next closing price was 0.27% . The trading price change to the current price is 0.27% . |
Synmosa Biopharma Fundamentals Correlations and Trends
By evaluating Synmosa Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Synmosa Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Synmosa financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Synmosa Biopharma Stock history
Synmosa Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Synmosa is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Synmosa Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Synmosa Biopharma stock prices may prove useful in developing a viable investing in Synmosa Biopharma
Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan. The company was incorporated in 1980 and is based in Taipei, Taiwan. SYNMOSA BIOPHARMA operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.
Synmosa Biopharma Stock Technical Analysis
Synmosa Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Synmosa Biopharma Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Synmosa Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on Taiwan OTC Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Synmosa Biopharma November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Synmosa Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Synmosa Biopharma shares will generate the highest return on investment. By undertsting and applying Synmosa Biopharma stock market strength indicators, traders can identify Synmosa Biopharma entry and exit signals to maximize returns
Synmosa Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Synmosa Biopharma's price direction in advance. Along with the technical and fundamental analysis of Synmosa Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Synmosa to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.27) | |||
| Treynor Ratio | (0.93) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Synmosa Stock Analysis
When running Synmosa Biopharma's price analysis, check to measure Synmosa Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synmosa Biopharma is operating at the current time. Most of Synmosa Biopharma's value examination focuses on studying past and present price action to predict the probability of Synmosa Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synmosa Biopharma's price. Additionally, you may evaluate how the addition of Synmosa Biopharma to your portfolios can decrease your overall portfolio volatility.